跳转至内容
Merck
CN

MTOXH1005

Cryopreserved Primary Human Hepatocytes Suspension

human liver (hepatocytes)

别名:

Primary Human Hepatocytes

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352207
NACRES:
NA.81
Biological source:
human liver (hepatocytes)
Relevant disease(s):
non-alcoholic steatohepatitis (NASH); non-alcoholic/simple fatty liver (NAFL)
Growth mode:
suspension
Manufacturer/tradename:
LifeNet Health®
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Cryopreserved Primary Human Hepatocytes Suspension,

biological source

human liver (hepatocytes)

form

liquid

packaging

vial of ≥5 mil. cells

manufacturer/tradename

LifeNet Health®

growth mode

suspension

technique(s)

cell culture | mammalian: suitable, genotyping: suitable

application(s)

ADME/TOX

relevant disease(s)

non-alcoholic steatohepatitis (NASH); non-alcoholic/simple fatty liver (NAFL)

shipped in

liquid nitrogen

storage temp.

−196°C

General description

We provide high viability cryopreserved hepatocytes, sourced from LifeNet Health® that predictably represents in vivo conditions. Applications for primary hepatocytes include in vitro evaluation of metabolism, drug-drug interaction, drug transporter activity, and toxicity of drug candidates. There are many other applications that encompass cryopreserved hepatocytes.

Application

See technical bulletins for detailed protocols.

Click lot availability link to get a complete list of currently available hepatocyte lots from LifeNet Health®.

Once the lot number(s) of interest are determined enter the lot number into the “Certificate of Analysis” request search engine at the bottom of the page to obtain a pdf copy of the CoA. Note, lot number CoA upload is only available on the product number detail page corresponding with the lot number.

Features and Benefits

These cryopreserved hepatocytes are sourced from LifeNet Health®. All cryopreserved hepatocytes have post-thaw viabilities over 80%. These lots are also characterized for Phase I CYP450 isoform and Phase II drug-metabolizing enzyme activity. Cryopreserved hepatocytes can be used for a variety of applications including metabolic stability, clearance, metabolite ID, metabolite profiling, species comparison studies, and uptake transporter studies.

Each lot is fully characterized for viability/stability, cell yield, attachment efficiency, optimal seeding density, monolayer confluency, Phase I and Phase II drug metabolizing enzyme activities and cyp induction. We have a wide selection of lots that can be used for a variety of applications, including, but not limited to:

  • Drug metabolizing enzyme activity (stability, clearance, metabolite profiling and ID)
  • Time-dependent metabolism (plated assay for low-clearance compounds)
  • CYP450 Induction (mRNA and activity)
  • Plated drug transporter assays (uptake and efflux)
  • Toxicity assays
  • High content analysis
  • High content imaging
  • 3D culture

Packaging

This product will be shipped in a liquid nitrogen dry shipper supplied from Cryoport. Please remember to ship the container back to Cryoport once you have removed the materials. Additional Cryoport shipping charges may apply.

Please see the Cryoport website for more details on the dry shipper.

Legal Information

LifeNet Health is a registered trademark of LifeNet Health

存储类别

10 - Combustible liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

高风险级别生物产品--人源产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持